In May 2022, Sweden’s National Board of Health and Welfare (NBHW announced it will no longer provide puberty blockers and sex hormones to those under the age of 18 as part of its transgender treatment, CBN reports.
It made the changes over precautionary concerns about the effectiveness of such treatments.
Previously, the government had provided puberty blockers to those as young as eight but had noted in a draft statement that desires for gender change in pre-pubescent children most often end when they enter puberty.
Recently the NBHW has announced further changes stating it will now be focusing on psychological counselling for those experiencing gender dysphoria under the age of 18, instead of pushing other procedures such as mastectomies.
In the guidelines, updating its policy, the NBHW’s head, Thomas Lindén, said:
“Young people who suffer from gender dysphoria need to be able to quickly receive an investigation and be offered adequate care measures, based on the health and medical services’ assessments of the care needs. Good psychosocial care is fundamental.“